Hikma at a glance
Discover what drives us
Latest news
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
- Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respectively Press Release, Product 19 January 2026 Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respectively
- Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment Press Release, Corporate 15 January 2026 Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment
- Exploring partnership opportunities with Hikma Pharmaceuticals. A Q&A with, Faisal Darwazeh VP of Group Business Development & Alliances Insight, Corporate 07 January 2026 Exploring partnership opportunities with Hikma Pharmaceuticals. A Q&A with, Faisal Darwazeh VP of Group Business Development & Alliances
- Hikma announces CEO change and Board appointment Press Release, Corporate 15 December 2025 Hikma announces CEO change and Board appointment